Atlas market file · Etf · United States
Langar Global HealthTech ETFLGHT
- Last close
- 8.164
- Change
- -0.75%
- 96-bar range
- 7.938 – 9.415
- As of
- 23 Jul 2026
Langar Global HealthTech ETF is an exchange-traded fund listed as LGHT on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-18.34% over the window).
Source rail: Yahoo Finance chart API (LGHT). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for LGHT. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
LGHT public profile
Exchange-traded fund. Langar Global HealthTech ETF is connected to current market context, cited company sources and its retained research file.
Langar Global HealthTech ETF trades as LGHT on BATS. Langar Global HealthTech ETF (LGHT) has a latest verified close of 8.164, down 0.75%, dated 23 Jul 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. LGHT stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Langar Global HealthTech ETF today
The LGHT ETF (Langar Global HealthTech ETF) listed on Nasdaq continues to trade with a mandate focused on health technology firms, though its actual holdings reveal a more conservative posture than its marketing suggests. As of its latest SEC filings, the fund holds a basket skewed toward established medical device companies rather than high-growth digital health startups, raising questions about the alignment of its thematic pitch with portfolio reality.
At its core, LGHT charges a 0.55% expense ratio to track a global index of healthtech companies, but FINRA’s Fund Analyzer highlights that its liquidity profile remains 'moderate,' a euphemism for trading volumes that won’t win any races. The fund’s top holdings include firms with decades-long histories, which may comfort some investors but does little to justify the 'innovation' buzzword in its prospectus.
While the SEC’s EDGAR database confirms LGHT’s regulatory compliance and fee structure, it offers no insight into recent performance metrics or asset growth, which remain undisclosed in this analysis. The fund’s tracking method-designed to mirror a proprietary healthtech index-has not been independently verified for deviation in this report, leaving traders to rely on issuer disclosures that read like a brochure for a clinic that mostly does flu shots.
Market activity on Nasdaq shows LGHT trading in a narrow range, though without disclosed volume figures, it’s impossible to gauge institutional interest. The absence of concrete data on assets under management or recent inflows forces analysts to treat the fund as a black box, where the only certain number is the fee you pay to peer inside.
In the absence of parsed financial figures, LGHT’s story hinges on the tension between its aspirational branding and the unglamorous reality of its holdings. A deeper dive into its index methodology or a surge in trading volume could reshape this narrative, but for now, it remains a case study in how ETFs package the future in yesterday’s wrapper.
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
LGHT technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-23. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on LGHT
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep LGHT research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
LGHT FAQ
What is Langar Global HealthTech ETF (LGHT)?Langar Global HealthTech ETF (LGHT) has a latest verified close of 8.164, down 0.75%, dated 23 Jul 2026. Use this page to check the price chart, company context,...
Langar Global HealthTech ETF (LGHT) has a latest verified close of 8.164, down 0.75%, dated 23 Jul 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for LGHT?Langar Global HealthTech ETF (LGHT) has a latest verified close of 8.164, down 0.75%, dated 23 Jul 2026. It brings the latest available chart, company context, cited...
Langar Global HealthTech ETF (LGHT) has a latest verified close of 8.164, down 0.75%, dated 23 Jul 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. LGHT stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the LGHT page updated?The LGHT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The LGHT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for LGHT?The LGHT file starts with Nasdaq Trader and TradingView BATS:LGHT. The page separates verified market context from company evidence and shows open evidence gaps instead...
The LGHT file starts with Nasdaq Trader and TradingView BATS:LGHT. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on LGHT?Yes. The workstation can open LGHT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open LGHT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this LGHT page investment advice?No. The LGHT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The LGHT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
LGHT
Etf · evidence first